Trial Profile
Phase III trial of bremelanotide for erectile dysfunction.
Status:
Suspended
Phase of Trial:
Phase III
Latest Information Update: 06 Sep 2007
Price :
$35
*
At a glance
- Drugs Bremelanotide (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors King Pharmaceuticals; Palatin Technologies
- 06 Sep 2007 New trial record.